Page précédente
Abstracts Strasbourg 2004
| Type présentation | Jour(s) | N° Session | N° | Auteurs | Titre | Adresses |
|---|---|---|---|---|---|---|
| Poster | 26-28 | 35 | P257 | E. M. Billaud (1); G. Henneré (1); E. Corbé (1); M. H. Pham (1); A. Lillo-Le louët (1); | Switch itraconazole-voriconazole : think TDMs Abstract complet |
(1) Service de Pharmacologie-Toxicologie, Hôpital Européen Georges Pompidou, Paris; |
| Poster | 26-28 | 35 | P258 | JM Poirier (1); O Zouai (1); JL Meynard (2); PM Girard (2); P Jaillon (1); | Inter-individual and intra-patient variability in lopinavir and ritonavir trough plasma concentrations in HIV-Infected Patients Abstract complet |
(1) Department of Pharmacology, Saint-Antoine University Hospital, Paris; (2) Department of Infectious Diseases, Saint-Antoine University Hospital, Paris; |
| Poster | 26-28 | 35 | P259 | V Jullien (1); S Urien (2); J Dimet (1); E Rey (1); N Dupin (3); D Salmon (4); G Pons (1); JM Treluyer (1); | Risk of undertreatment with the standard abacavir 300mg dose Abstract complet |
(1) Pharmacologie Clinique, Hôpital Cochin – Saint Vincent de Paul, Paris; (2) Pharmacologie Clinique, Hôpital Rene Huguenin, St Cloud; (3) Dermatologie, Hôpital Cochin – Saint Vincent de Paul, Paris; (4) Medecine Interne, Hôpital Cochin – Saint Vincent de Paul, Paris; |
| Poster | 26-28 | 35 | P260 | A Blesius (1); S Chabaud (1); M Cucherat (1); P Mismetti (2); JP Boissel (1); P Nony (1); | Potential consequences of drug non-compliance on the therapeutic / iatrogenic effects of oral anticoagulant therapy : an “in silico” study Abstract complet |
(1) Service de Pharmacologie Clinique, EA3736 , Faculté Laennec, Lyon; (2) Service de Pharmacologie Clinique, Hopital Bellevue, Saint Etienne; |
| Poster | 26-28 | 35 | P261 | O Tribut (1); A Maillard (2); JM Chapplain (3); M Chantret (2); C Arvieux (3); C Michelet (3); H Allain (1); D Bentué-Ferrer (1); A Ruffault (2); | Interest of genotypic inhibitory quotient (GIQ) in improving the prediction of lopinavir-ritonavir response in human immunodeficiency virus type 1 (HIV-1) protease inhibitor-experienced patients Abstract complet |
(1) Service de Pharmacologie, CHU de Rennes, Rennes; (2) Service de Virologie, CHU de Rennes, Rennes; (3) Service des Maladies Infectieuses, CHU de Rennes, Rennes; |
| Poster | 26-28 | 35 | P262 | A Lemaire-Hurtel (1); H Masson (1); H Morant (1); L Hary (1); | Automated solid phase extraction method for the extraction of 8 antiretrovirals simultaneously coupled to an on line quantification by high performance liquid chromatography Abstract complet |
(1) Service de Pharmacologie, CHU Amiens, Amiens; |
| Poster | 26-28 | 35 | P263 | C Le Guellec (1); P Rodon (2); F Bastide (2); T Prazuck (2); W De Jong (3); C Michelet (4); F Raffi (5); E Autret-Leca (1); G. Paintaud (1); P Choutet (2); JM Besnier (2); | Bayesian Estimation of Nelfinavir Exposure Based on a Model Integrating Diurnal and Food-Effects Abstract complet |
(1) Service de Pharmacologie, CHU, Tours; (2) CISIH, CHU, Tours; (3) Centre de Recherche Clinique, CHU, Tours; (4) Maladies Infectieuses, CHU, Rennes; (5) Maladies Infectieuses, CHU, Nantes; |
| Poster | 26-28 | 35 | P264 | G Hardy (1); F Stanke-Labesque (1); C Contamin (2); F Serre-Debeauvais (1); F Bayle (2); P Zaoui (2); G Bessard (1); | Interaction between tacrolimus and protease inhibitors in a renal transplant patient Abstract complet |
(1) Laboratoire de Pharmacologie, CHU de Grenoble, Grenoble; (2) Département de Néphrologie, CHU de Grenoble, Grenoble; |
| Poster | 26-28 | 35 | P265 | T Trenque (1); I Villena (2); N Simon (3); C Marx (2); C Quereux (4); B Leroux (4); G Remy (4); R Jaussaud (4); A Molia (1); H Millart (1); JM Pinon (2); S Urien (5); | Congenital toxoplasmosis: population pharmacokinetics of pyrimethamine and sulfadoxine in pediatric patients Abstract complet |
(1) Laboratoire de Pharmacologie, Centre Hospitalier Universitaire, Reims; (2) Laboratoire de Parasitologie, Centre Hospitalier Universitaire, Reims; (3) Faculté de Médecine, Université de Marseille, Marseille; (4) Reims Toxoplasmosis Group, Centre Hospitalier Universitaire, Reims; (5) Laboratoire de Pharmacologie, Centre René Huguenin, Saint Cloud; |
| Poster | 26-28 | 35 | P266 | MC Verdier (1); O Tribut (1); P Tattevin (2); C Michelet (2); H Allain (1); D Bentué-Ferrer (1); | Beta-lactamin: Therapeutic drug monitoring versus dosing adaptation with creatinine level Abstract complet |
(1) Service de Pharmacologie, CHU de Rennes, Rennes; (2) Service des Maladies Infectieuses, CHU de Rennes, Rennes; |
| Poster | 26-28 | 35 | P267 | O Tribut (1); C Gastel (1); MC Verdier (1); PN D’Halluin (2); D Heresbach (2); H Allain (1); D Bentué-Ferrer (1); | Therapeutic Drug Monitoring of azathioprine: Red blood cells versus whole blood concentrations Abstract complet |
(1) Service de Pharmacologie, CHU de Rennes, Rennes; (2) Service de Gastroentérologie, CHU de Rennes, Rennes; |
| Poster | 26-28 | 35 | P268 | JM Lepage (1); D Debruyne (1); T Lobbedez (2); B Hurault De Ligny (2); A Coquerel (1); | Cyclosporine A monitoring in peripheral blood mononuclear cells Abstract complet |
(1) Service de Pharmacologie, CHRU, Caen; (2) Service de Néphrologie-Hémodialyse, CHRU, Caen; |
Page précédente